TickerFacts.

Madrigal Pharmaceuticals, Inc. (MDGL): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 5-for-4, first reflected in a filing dated 2026-05-06. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

22.84M
As of 2025-12-31
23.09M
As of 2026-06-30
+8.1%
3-year compound annual growth
+8.1%
5-year compound annual growth
n/m
10-year compound annual growth
109.12M2010-12-31: 42.09M2011-12-31: 49.54M2012-12-31: 68.93M2013-12-31: 85.23M2014-12-31: 109.12M2015-12-31: 176.2K2016-12-31: 11.95M2017-12-31: 14.23M2018-12-31: 15.41M2019-12-31: 15.43M2020-12-31: 15.51M2021-12-31: 17.10M2022-12-31: 18.10M2023-12-31: 19.88M2024-12-31: 22.00M2025-12-31: 22.84M22.84M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3122.84M+3.8%2026-02-19, Balance as of period end
2024-12-3122.00M+10.7%2026-02-19, Balance as of period end
2023-12-3119.88M+9.8%2025-02-26, Balance as of period end
2022-12-3118.10M+5.8%2024-02-28, Balance as of period end
2021-12-3117.10M+10.3%2023-03-03, Balance as of period end
2020-12-3115.51M+0.5%2022-02-24, Balance as of period end
2019-12-3115.43M+0.1%2021-02-25, Balance as of period end
2018-12-3115.41M+8.3%2020-02-26, Balance as of period end
2017-12-3114.23M+19.0%2019-02-27, Balance as of period end
2016-12-3111.95Mn/m2018-03-13, Balance as of period end
2015-12-31176.2K-99.8%2017-03-31, Balance as of period end
2014-12-31109.12M+28.0%2016-03-15, Balance as of period end
2013-12-3185.23M+23.7%2015-03-12, Balance as of period end
2012-12-3168.93M+39.1%2014-03-11, Balance as of period end
2011-12-3149.54M+17.7%2013-03-14, Balance as of period end
2010-12-3142.09Mn/a2012-02-22, Balance as of period end